
4-Channel Multimodal Ultrathin-Flexible SFE for cancer diagnosis and therapyAward last edited on: 9/21/17
Sponsored Program
SBIRAwarding Agency
NIH : NCITotal Award Amount
$300,000Award Phase
1Solicitation Topic Code
102Principal Investigator
Gerald McMorrowCompany Information
Veravanti Inc
2260 152nd Avenue Ne Suite 200
Redmond, WA 98052
Redmond, WA 98052
(425) 201-6070 |
info@veravanti.com |
www.veravanti.com |
Location: Single
Congr. District: 01
County: King
Congr. District: 01
County: King
Phase I
Contract Number: 1R43CA211086-01A1Start Date: 5/15/17 Completed: 7/31/18
Phase I year
2017Phase I Amount
$300,000Public Health Relevance Statement:
Project Narrative This SFE endoscope technology was developed by the University of Washington and licensed to VerAvanti for rapidly bringing to the clinic as a commercial product. This project in collaboration with the University of Washington inventors will demonstrate the technical feasibility that this multimodal imaging technology offers in more accurately guiding cancer diagnosis and surgically removing tumors.
Project Terms:
3D Print; Adult; Area; Awareness; base; Benchmarking; Binding; Biopsy; Brain; Brain Neoplasms; brain surgery; brain tissue; brain tumor resection; Caliber; cancer cell; cancer diagnosis; cancer imaging; Cancer Intervention; cancer therapy; Chlorotoxin; Clinic; Clinical; clinical application; Clinical Trials; Collaborations; Color; commercialization; Computer software; contrast enhanced; cost; Custom; design; Detection; detector; Development; Duct (organ) structure; Ductal; Dyes; Early Diagnosis; Endoscopes; Engineering; Esophagus; Excision; Feedback; Fiber; flexibility; Fluorescence; fluorescence imaging; Future; gastrointestinal; Goals; Image; image guided; Image-Guided Surgery; Imaging technology; Incentives; Indocyanine Green; Intervention; Knowledge; Label; Lasers; Left; Letters; Licensing; Life; Light; Lighting; Malignant neoplasm of gastrointestinal tract; Malignant Neoplasms; Medical Device; Medical Imaging; Medical Technology; Michigan; minimally invasive; Molecular; molecular imaging; Molecular Probes; Multi-Institutional Clinical Trial; Multimodal Imaging; multimodality; Near-infrared optical imaging; Neurologic Deficit; Neurosurgeon; neurosurgery; Operative Surgical Procedures; optical fiber; optical imaging; Optics; Patients; Pattern; Peptides; Performance; Permeability; photon-counting detector; Photons; preference; prototype; Research; Research Personnel; Residual Tumors; Resolution; Safety; Scanning; Small Business Innovation Research Grant; Software Design; Solid Neoplasm; Specificity; System; Technology; Testing; Tissues; To specify; tool; Topical application; touchscreen; Translating; tumor; Tumor Tissue; Universities; Visible Radiation; Washington
Phase II
Contract Number: ----------Start Date: 00/00/00 Completed: 00/00/00